{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T10:53:43Z","timestamp":1781607223129,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Urinary tract cancers (UTC), particularly bladder and kidney cancers, are associated with high mortality rates globally. In Iran, and specifically in Golestan province, an increasing trend in the incidence of these cancers has been reported. This study aims to analyze cancer trends and inform health policy planning to reduce the burden of these diseases in Golestan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data was collected from the Golestan Population-Based Cancer Registry (GPCR) covering cases of UTC, particularly kidney and bladder cancer from 2004 to 2019. Crude and age-standardized rates (ASR) of kidney and bladder cancers were calculated and presented per 100,000 person-years. Estimated annual percent changes (EAPC) of the ASRs were calculated to investigate time trends in incidence rates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The ASR for kidney cancer was 2.32 per 100,000, with rates of 2.75 for men and 1.91 for women. Bladder cancer had an ASR of 5.93, with 9.46 in men and 2.52 in women. Urban populations experienced higher incidence rates as 2.71 for kidney cancer and 7.01 for bladder cancer versus 1.87 and 4.80 in rural areas, respectively. The estimated annual percentage change in incidence was 3.68% for kidney and 1.56% for bladder cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings suggest high rates and increasing trends in incidence of kidney and bladder cancers in Golestan. The study indicates higher kidney and bladder cancer rates in men and urban residents. Further investigations are warranted to assess the effects of risk factors like smoking, opioid drug use and agricultural factors on incidence of urinary tract cancers in this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-025-14641-8","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T15:34:54Z","timestamp":1753716894000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trends in urinary tract cancer incidence in Golestan province, Iran: a 16-year population-based study"],"prefix":"10.1186","volume":"25","author":[{"given":"Behnaz","family":"Rahatijafarabad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AmirHoushang","family":"Poorkhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Esfandiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SeyyedMehdi","family":"Sedaghat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Ghasemi-Kebria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Hasanpour-Heidari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeid","family":"Amirkhanlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamreza","family":"Roshandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"key":"14641_CR1","doi-asserted-by":"crossref","unstructured":"Hassanipour S, Namvar G, Fathalipour M, Salehiniya H. The incidence of kidney cancer in iran: a systematic review and meta-analysis. Biomedicine. 2018;8(2):9.","DOI":"10.1051\/bmdcn\/2018080209"},{"issue":"4","key":"14641_CR2","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/bju.15483","volume":"128","author":"S Khadhouri","year":"2021","unstructured":"Khadhouri S, Gallagher KM, MacKenzie KR, Shah TT, Gao C, Moore S, et al. The IDENTIFY study: the investigation and detection of urological neoplasia in patients referred with suspected urinary tract cancer\u2013a multicentre observational study. BJU Int. 2021;128(4):440\u201350.","journal-title":"BJU Int"},{"issue":"2","key":"14641_CR3","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.eururo.2023.03.029","volume":"84","author":"I Jubber","year":"2023","unstructured":"Jubber I, Ong S, Bukavina L, Black PC, Comp\u00e9rat E, Kamat AM, et al. Epidemiology of bladder cancer in 2023: a systematic review of risk factors. Eur Urol. 2023;84(2):176\u201390.","journal-title":"Eur Urol"},{"key":"14641_CR4","unstructured":"Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L et al. Global Cancer Observatory: Cancer Today (version 1.1) Lyon, France: International Agency for Research on Cancer; 2024 Available from: https:\/\/gco.iarc.who.int\/today."},{"issue":"3","key":"14641_CR5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"Cancer J Clin"},{"issue":"2","key":"14641_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.21037\/tau.2020.02.24","volume":"9","author":"Q Cai","year":"2020","unstructured":"Cai Q, Chen Y, Xin S, Zhang D, Pan J, Xie Z, et al. Temporal trends of bladder cancer incidence and mortality from 1990 to 2016 and projections to 2030. Translational Androl Urol. 2020;9(2):153.","journal-title":"Translational Androl Urol"},{"key":"14641_CR7","doi-asserted-by":"crossref","unstructured":"Nowroozi MR, Amini E, Farkhani EM, Nowroozi A, Ayati M, Momeni SA, et al. National and Subnational Incidence Trend of Bladder Cancer in Iran: Report of a 12-Year Period. Int J Cancer Manage. 2023;16(1):e127005.","DOI":"10.5812\/ijcm-127005"},{"key":"14641_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40364-020-00195-3","volume":"8","author":"Z Du","year":"2020","unstructured":"Du Z, Chen W, Xia Q, Shi O, Chen Q. Trends and projections of kidney cancer incidence at the global and national levels, 1990\u20132030: a bayesian age-period-cohort modeling study. Biomark Res. 2020;8:1\u201310.","journal-title":"Biomark Res"},{"key":"14641_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2020.101728","volume":"67","author":"G Roshandel","year":"2020","unstructured":"Roshandel G, Ferlay J, Semnani S, Fazel A, Naeimi-Tabiei M, Ashaari M, et al. Recent cancer incidence trends and short-term predictions in Golestan, Iran 2004\u20132025. Cancer Epidemiol. 2020;67: 101728.","journal-title":"Cancer Epidemiol"},{"key":"14641_CR10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.canep.2017.12.014","volume":"52","author":"G Roshandel","year":"2018","unstructured":"Roshandel G, Semnani S, Fazel A, Honarvar M, Taziki M, Sedaghat S, et al. Building cancer registries in a lower resource setting: the 10-year experience of Golestan, Northern Iran. Cancer Epidemiol. 2018;52:128\u201333.","journal-title":"Cancer Epidemiol"},{"key":"14641_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2020.101687","volume":"65","author":"F Salamat","year":"2020","unstructured":"Salamat F, Khandashpour M, Naeimi-Tabiei M, Ariannia A, Ashaari M, Sedaghat S, et al. Increasing trends of lung cancer in Golestan province, Northern Iran (2004\u20132016). Cancer Epidemiol. 2020;65: 101687.","journal-title":"Cancer Epidemiol"},{"key":"14641_CR12","unstructured":"Forman D, Bray F, Brewster D, Gombe Mbalawa C, Kohler B, Pi\u00f1eros M et al. Cancer incidence in five continents, Vol. X. Lyon: International Agency for Research on Cancer; 2014."},{"key":"14641_CR13","volume-title":"Cancer incidence in five continents","author":"F Bray","year":"2023","unstructured":"Bray F, Colombet M, Aitken JF, Bardot A, Eser S, Galceran J. Cancer incidence in five continents. Lyon: International Agency for Research on Cancer; 2023."},{"key":"14641_CR14","unstructured":"Jensen OM. Cancer registration: principles and methods. Lyon: International Agency for Research on Cancer; 1991."},{"issue":"4","key":"14641_CR15","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/00008469-200508000-00002","volume":"14","author":"WG Report","year":"2005","unstructured":"Report WG. International rules for multiple primary cancers (ICD-0 third edition). Eur J cancer Prevention: Official J Eur Cancer Prev Organisation (ECP). 2005;14(4):307\u20138.","journal-title":"Eur J cancer Prevention: Official J Eur Cancer Prev Organisation (ECP)"},{"key":"14641_CR16","volume-title":"International classification of diseases for oncology, World Health Organization","author":"World Health Organization","year":"2000","unstructured":"World Health Organization. International classification of diseases for oncology, World Health Organization. Geneva, Switzerland: World Health Organization; 2000."},{"key":"14641_CR17","unstructured":"Segi M. Cancer mortality for selected sites in 24 countries (1950\u20131957). Tohoku: Japan Cancer Society; 1960."},{"key":"14641_CR18","volume-title":"Cancer registry data analysis and visualisation. R package version 1.3.72","author":"M Laversanne","year":"2019","unstructured":"Laversanne M, Vignat J, Rcan. Cancer registry data analysis and visualisation. R package version 1.3.72. Lyon: Internationa Agency for Research on Cancer, Section for Cancer Surveillance; 2019."},{"issue":"1","key":"14641_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12939-023-02084-1","volume":"23","author":"A-H Mousavian","year":"2024","unstructured":"Mousavian A-H, Shafiee G, Sheidaei A, Balajam NZ, Ebrahimi M, Khatami F, et al. The 15-year national trends of urinary cancers incidence among Iranian men and women; 2005\u20132020. Int J Equity Health. 2024;23(1):13.","journal-title":"Int J Equity Health"},{"issue":"6","key":"14641_CR20","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.eururo.2020.09.006","volume":"78","author":"JY-C Teoh","year":"2020","unstructured":"Teoh JY-C, Huang J, Ko WY-K, Lok V, Choi P, Ng C-F, et al. Global trends of bladder cancer incidence and mortality, and their associations with tobacco use and gross domestic product per capita. Eur Urol. 2020;78(6):893\u2013906.","journal-title":"Eur Urol"},{"issue":"1","key":"14641_CR21","volume":"8","author":"K Saginala","year":"2020","unstructured":"Saginala K, Barsouk A, Aluru JS, Rawla P, Padala SA, Barsouk A. Epidemiology of bladder cancer. Med Sci. 2020;8(1): 15.","journal-title":"Med Sci"},{"key":"14641_CR22","doi-asserted-by":"crossref","unstructured":"Alcala K, Poustchi H, Viallon V, Islami F, Pourshams A, Sadjadi A et al. Incident cancers attributable to using opium and smoking cigarettes in the Golestan cohort study. EClinicalMedicine. 2023;64:102229.","DOI":"10.1016\/j.eclinm.2023.102229"},{"issue":"6","key":"14641_CR23","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1136\/tobaccocontrol-2016-053245","volume":"26","author":"A Etemadi","year":"2017","unstructured":"Etemadi A, Khademi H, Kamangar F, Freedman ND, Abnet CC, Brennan P, et al. Hazards of cigarettes, smokeless tobacco and waterpipe in a middle Eastern population: a cohort study of 50 000 individuals from Iran. Tob Control. 2017;26(6):674\u201382.","journal-title":"Tob Control"},{"issue":"6","key":"14641_CR24","doi-asserted-by":"publisher","first-page":"612","DOI":"10.26719\/emhj.21.018","volume":"27","author":"M Aryaie","year":"2021","unstructured":"Aryaie M, Sharifi H, Khorrami Z, Ardalan G, Rajaei L, Heydari G, et al. Prevalence of cigarette smoking in Iranian adolescents and young adults: a systematic review and meta-analysis. East Mediterr Health J. 2021;27(6):612\u201328.","journal-title":"East Mediterr Health J"},{"key":"14641_CR25","volume-title":"Bladder cancer risk from occupational and environmental exposures","year":"2012","unstructured":"Kiriluk KJ, Prasad SM, Patel AR, Steinberg GD, Smith ND, editors. Bladder cancer risk from occupational and environmental exposures. Urologic Oncology: Seminars and Original Investigations; 2012."},{"issue":"3","key":"14641_CR26","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/jnci\/djad218","volume":"116","author":"A Etemadi","year":"2024","unstructured":"Etemadi A, Poustchi H, Chang CM, Calafat AM, Blount BC, Bhandari D, et al. Exposure to polycyclic aromatic hydrocarbons, volatile organic compounds, and tobacco-specific nitrosamines and incidence of esophageal cancer. JNCI: J Natl Cancer Inst. 2024;116(3):379\u201388.","journal-title":"JNCI: J Natl Cancer Inst"},{"issue":"4","key":"14641_CR27","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/ijc.33588","volume":"149","author":"J Ferlay","year":"2021","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Pi\u00f1eros M, Znaor A, et al. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021;149(4):778\u201389.","journal-title":"Int J Cancer"},{"issue":"20","key":"14641_CR28","first-page":"2019","volume":"3","author":"J Ferlay","year":"2018","unstructured":"Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Pi\u00f1eros M, et al. Global cancer observatory: cancer today. Lyon France: Int Agency Res cancer. 2018;3(20):2019.","journal-title":"Lyon France: Int Agency Res cancer"},{"issue":"1","key":"14641_CR29","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.euf.2020.12.020","volume":"8","author":"J Huang","year":"2022","unstructured":"Huang J, Leung DK-W, Chan EO-T, Lok V, Leung S, Wong I, et al. A global trend analysis of kidney cancer incidence and mortality and their associations with smoking, alcohol consumption, and metabolic syndrome. Eur Urol Focus. 2022;8(1):200\u20139.","journal-title":"Eur Urol Focus"},{"issue":"1","key":"14641_CR30","first-page":"782381","volume":"2008","author":"D Pascual","year":"2008","unstructured":"Pascual D, Borque A. Epidemiology of kidney cancer. Adv Urol. 2008;2008(1):782381.","journal-title":"Adv Urol"},{"issue":"6","key":"14641_CR31","doi-asserted-by":"publisher","first-page":"067011","DOI":"10.1289\/EHP6334","volume":"128","author":"G Andreotti","year":"2020","unstructured":"Andreotti G, Beane Freeman LE, Shearer JJ, Lerro CC, Koutros S, Parks CG, et al. Occupational pesticide use and risk of renal cell carcinoma in the agricultural health study. Environ Health Perspect. 2020;128(6):067011.","journal-title":"Environ Health Perspect"},{"issue":"4","key":"14641_CR32","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/jhh.2015.57","volume":"30","author":"S Sepanlou","year":"2016","unstructured":"Sepanlou S, Sharafkhah M, Poustchi H, Malekzadeh M, Etemadi A, Khademi H, et al. Hypertension and mortality in the Golestan cohort study: a prospective study of 50 000 adults in Iran. J Hum Hypertens. 2016;30(4):260\u20137.","journal-title":"J Hum Hypertens"},{"key":"14641_CR33","doi-asserted-by":"publisher","first-page":"1115833","DOI":"10.3389\/fendo.2023.1115833","volume":"14","author":"SA Nejadghaderi","year":"2023","unstructured":"Nejadghaderi SA, Saeedi Moghaddam S, Keykhaei M, Shobeiri P, Rezaei N, Rezaei N, et al. Trends of national and sub-national burden attributed to kidney dysfunction risk factor in Iran: 1990\u20132019. Front Endocrinol. 2023;14:1115833.","journal-title":"Front Endocrinol"},{"issue":"1","key":"14641_CR34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.canlet.2015.10.003","volume":"370","author":"R Zheng","year":"2016","unstructured":"Zheng R, Zeng H, Zhang S, Chen T, Chen W. National estimates of cancer prevalence in China, 2011. Cancer Lett. 2016;370(1):33\u20138.","journal-title":"Cancer Lett"},{"issue":"1","key":"14641_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.18869\/acadpub.jcbr.1.1.27","volume":"1","author":"H Rahimzadeh","year":"2017","unstructured":"Rahimzadeh H, Sadeghi M, Beirami S, Bay A, Mansurian M, Roshandel G. Association of heavy metals and selenium content in rice with incidence of esophageal cancer in Golestan province, Iran. J Clin Basic Res. 2017;1(1):27\u201332.","journal-title":"J Clin Basic Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14641-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14641-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14641-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T10:09:35Z","timestamp":1781604575000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-025-14641-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14641"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14641-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"assertion":[{"value":"10 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In adherence to the Declaration of Helsinki, ethical considerations were taken into account to protect the privacy and confidentiality of the patient\u2019s data. In this study, we obtained de-identified data from the Golestan Cancer Registry dataset, and we did not collect data directly from the participants. Therefore, the need for consent to participate was waived by the ethics committee of the Golestan University of Medical Sciences. The study protocol was reviewed and approved by the Ethics Committee of the Golestan University of Medical Sciences, Gorgan, Iran (Ethics code: IR.GOUMS.REC.1403.014).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1227"}}